These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1755574)

  • 21. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in computer-based pharmacy systems.
    Weissman AM; Burleson KW
    Med Instrum; 1978; 12(4):237-40. PubMed ID: 692469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands.
    Becker ML; Caspers PW; Kallewaard M; Bruinink RJ; Kylstra NB; Heisterkamp S; de Valk V; van der Veen AA; Stricker BH
    Pharm World Sci; 2007 Apr; 29(2):51-7. PubMed ID: 17187223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.
    Lamers LM; van Vliet RC
    Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1995 National Clinical Pharmacy Services Study.
    Raehl CL; Bond CA; Pitterle ME
    Pharmacotherapy; 1998; 18(2):302-26. PubMed ID: 9545150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands.
    Schirm E; Pedersen L; Tobi H; Nielsen GL; Sørensen HT; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):609-13. PubMed ID: 15362083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children.
    Schirm E; Tobi H; de Jong-van den Berg LT
    J Clin Epidemiol; 2004 Jul; 57(7):737-41. PubMed ID: 15358402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heavy consumers of drugs--seen from the viewpoint of the community pharmacist].
    Mellbye KS; Berg C
    Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3069-71. PubMed ID: 15586191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategic opportunities for effective optimal prescribing and medication management.
    Sketris IS; Langille Ingram EM; Lummis HL
    Can J Clin Pharmacol; 2009; 16(1):e103-25. PubMed ID: 19182305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse.
    Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacology at the start of a new millennium. Larger assortment and individual drug dosing are coming].
    Fredholm BB; Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):534-9. PubMed ID: 11475239
    [No Abstract]   [Full Text] [Related]  

  • 37. Developing a comprehensive medication reaction reporting system.
    Yee WP; Norton LL; Catania HF
    Hosp Pharm; 1995 May; 30(5):384-5, 389-91, 394-6. PubMed ID: 10142377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using computer databases to predict and avoid drug-drug interactions in the cancer patient requiring psychotropics.
    Strain JJ; Caliendo G; Himelein C
    Psychooncology; 1998; 7(4):321-32. PubMed ID: 9741071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status.
    Boudreau DM; Doescher MP; Saver BG; Jackson JE; Fishman PA
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):877-84. PubMed ID: 15931653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASHP national survey of hospital-based pharmaceutical services--1992.
    Crawford SY; Myers CE
    Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.